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Salicylanilides, 2-hydroxy-N-(phenyl)benzamides, represent a group with wide range of 
biological activities. They have been studied over time on the interest of medicinal chemistry 
for many interesting effects: act as uncouplers on biomembranes, affect productions of 
interleukins, regulate an immune response, show analgesic and anti-inflammatory properties, 
influence ion channels, affect some molecular targets being potentially useful in cancer therapy 
[1], express moderate hypoglycaemic activity [2], influence the metabotropic glutamate 
receptors [3]. Also, salicylanilide derivatives are known for their activity against different 
bacteria, fungi and protozoa, the basic structure is still modulated for antimycobacterial, 
antifungal and antibacterial activities [1, 4]. Starting from N-(4-chloro-phenyl)-2-hydroxy-
benzamide, novel molecules, esters, hydrazides, hydrazones were synthesized under microwave 
irradiation. The compounds were obtained with good yields (66-97%) after the final purification 
and were characterized using FTIR, 1H and 13C-NMR. Spectral data unambiguously confirm 
the proposed structures. 
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